Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 5 days ago

Vilanterol Trifenatate + Fluticasone Furoate + Umeclidinium Bromide

🌐 বাংলায় দেখুন

Indications

Vilanterol Trifenatate + Fluticasone Furoate + Umeclidinium Bromide is used for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). It is also used for the maintenance treatment of asthma in patients aged 18 years and older. Limitation of use: it is not indicated for relief of acute bronchospasm.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

This capsule contains an inhalation powder that delivers three medicines by oral inhalation: fluticasone furoate (an ICS), umeclidinium (an anticholinergic) and vilanterol (a LABA). The effects of beta 2-adrenoceptor agonists such as vilanterol come, at least in part, from stimulating intracellular adenyl cyclase. This enzyme catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3, 5 -adenosine monophosphate (cyclic AMP). Higher cyclic AMP levels relax the bronchial smooth muscle and inhibit the release of mediators of immediate hypersensitivity from cells, especially from mast cells. The precise way fluticasone furoate affects COPD and asthma symptoms is not known. Inflammation is an important part of how COPD and asthma develop, and corticosteroids have been shown to act on many cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, lymphocytes) and many mediators (e.g., histamine, eicosanoids, leukotrienes, cytokines) involved in inflammation. Umeclidinium is a long-acting muscarinic antagonist, often called an anticholinergic. It has similar affinity for the muscarinic receptor subtypes M1 to M5. In the airways, it works by inhibiting the M3 receptor at the smooth muscle, which leads to bronchodilation.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Don't swallow the Vilanterol Trifenatate + Fluticasone Furoate + Umeclidinium Bromide inhalation capsule. Use it only with the device, and take the capsule out of the blister pack just before you put it into the inhalation device. After inhaling, rinse your mouth with water without swallowing it, to reduce the risk of oropharyngeal candidiasis. Adults (18 years or older) should use the capsule at the same time every day, and not more than once every 24 hours. If shortness of breath or other asthma symptoms come on between doses, take an inhaled SABA (Short Acting β-Agonist) for immediate relief. Maintenance treatment of COPD: 1 inhalation capsule once daily. Maintenance treatment of Asthma: 1 inhalation capsule once daily.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.

Key Interactions

Checker →